The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A molecular biomarker for longitudinal monitoring of therapeutic efficacy in a real-world cohort of advanced solid tumors treated with immune checkpoint inhibitors.
 
John Guittar
Employment - Myriad Genetics; Tempus AI
Stock and Other Ownership Interests - Myriad Genetics; Tempus AI
 
Michelle Stein
Employment - Tempus
Stock and Other Ownership Interests - Tempus
Patents, Royalties, Other Intellectual Property - Tempus
Travel, Accommodations, Expenses - Tempus
 
Victoria Chiou
Employment - AstraZeneca; Tempus AI, Inc.
Stock and Other Ownership Interests - AstraZeneca
Research Funding - AstraZeneca; Tempus AI, Inc.
Travel, Accommodations, Expenses - AstraZeneca; Tempus AI, Inc.
 
Halla Nimeiri
Employment - Northwestern Medicine; Tempus AI
Stock and Other Ownership Interests - Abbvie; Tempus AI
 
Ali Zaidi
Stock and Other Ownership Interests - Previse; TG Therapeutics
Consulting or Advisory Role - BillionToOne; Delfi Diagnostics; Gilead Sciences; PrognomIQ
Research Funding - BillionToOne; Delfi Diagnostics; Exai Bio; Genece Health; Myriad Genetics; PrognomIQ; Roche/Genentech; Tempus
 
Daniel Morgensztern
Stock and Other Ownership Interests - Abbott Laboratories; Bristol-Myers Squibb/Medarex
Consulting or Advisory Role - Abbvie; Arcus Biosciences; Bayer; Bristol-Myers Squibb/Medarex; G1 Therapeutics; Johnson & Johnson/Janssen; Lilly Medical; Mirati Therapeutics; Natera; Tubulis GmbH
Research Funding - Abbvie (Inst); Altum Pharmaceuticals (Inst); Arcus Biosciences (Inst); Array BioPharma (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Baxter (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); EpicentRx (Inst); Genprex (Inst); Heat Biologics (Inst); Hybercell (Inst); ImmunityBio (Inst); Incyte (Inst); Lilly (Inst); Merck (Inst); NeoImmuneTech (Inst); Pfizer (Inst); Roche (Inst); Surface Oncology (Inst); Y-mAbs Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Genprex
 
Rotem Ben-Shachar
Employment - Myriad Genetics; Tempus AI
Stock and Other Ownership Interests - Myriad Genetics; Tempus
 
Aadel Chaudhuri
Employment - Mayo Clinic
Leadership - CytoTrace Biosciences; Droplet Biosciences; LiquidCell Dx
Stock and Other Ownership Interests - CytoTrace Biosciences; Droplet Biosciences; Geneoscopy; LiquidCell Dx
Honoraria - Agilent; Illumina
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Caris Life Sciences (Inst); Geneoscopy; Guardant Health (Inst); Illumina; InVitae; Myriad Genetics; Roche
Research Funding - Tempus
Patents, Royalties, Other Intellectual Property - I have patent filings related to cancer biomarkers, and have received royalties related to licensed technology.
Travel, Accommodations, Expenses - Droplet Biosciences; LiquidCell Dx
Other Relationship - Illumina (Inst); Roche (Inst)